Foundry Partners’s Avanos Medical AVNS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-119,870
| Closed | -$1.91M | – | 263 |
|
|
2024
Q4 | $1.91M | Sell |
119,870
-43,160
| -26% | -$687K | 0.1% | 209 |
|
|
2024
Q3 | $3.92M | Buy |
163,030
+1,800
| +1% | +$43.3K | 0.19% | 172 |
|
|
2024
Q2 | $3.21M | Sell |
161,230
-2,025
| -1% | -$40.3K | 0.17% | 175 |
|
|
2024
Q1 | $3.25M | Sell |
163,255
-207,774
| -56% | -$4.14M | 0.17% | 183 |
|
|
2023
Q4 | $8.32M | Buy |
371,029
+158,473
| +75% | +$3.55M | 0.5% | 53 |
|
|
2023
Q3 | $4.3M | Buy |
212,556
+39,068
| +23% | +$790K | 0.27% | 124 |
|
|
2023
Q2 | $4.43M | Buy |
173,488
+43,868
| +34% | +$1.12M | 0.27% | 108 |
|
|
2023
Q1 | $3.85M | Buy |
129,620
+120,200
| +1,276% | +$3.57M | 0.24% | 130 |
|
|
2022
Q4 | $255K | Sell |
9,420
-220
| -2% | -$5.96K | 0.01% | 287 |
|
|
2022
Q3 | $210K | Sell |
9,640
-185
| -2% | -$4.03K | 0.01% | 305 |
|
|
2022
Q2 | $269K | Hold |
9,825
| – | – | 0.02% | 273 |
|
|
2022
Q1 | $329K | Buy |
+9,825
| New | +$329K | 0.02% | 293 |
|